{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T07:58:20Z","timestamp":1793347100772,"version":"4.5.0"},"reference-count":37,"publisher":"Japanese Circulation Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1253\/circj.cj-15-0685","type":"journal-article","created":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T17:05:47Z","timestamp":1457456747000},"page":"938-949","source":"Crossref","is-referenced-by-count":25,"title":["Next Generation Sequencing and Linkage Analysis for the Molecular Diagnosis of a Novel Overlapping Syndrome Characterized by Hypertrophic Cardiomyopathy and Typical Electrical Instability of Brugada Syndrome"],"prefix":"10.1253","volume":"80","author":[{"given":"Ruggiero","family":"Mango","sequence":"first","affiliation":[{"name":"Department of Emergency and Critical Care, Section of Cardiology, Policlinic of Tor Vergata"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Luchetti","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, Tor Vergata University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Sangiuolo","sequence":"additional","affiliation":[{"name":"Ospedale Buon Consiglio Fatebenefratelli"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Ferradini","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, Tor Vergata University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Briglia","sequence":"additional","affiliation":[{"name":"Ospedale Buon Consiglio Fatebenefratelli"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiliano","family":"Giardina","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, Tor Vergata University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Ferr\u00e8","sequence":"additional","affiliation":[{"name":"Department of Biology, Tor Vergata University"},{"name":"Department of Pharmacology and Biotechnology, University of Bologna Alma Mater"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Helmer Citterich","sequence":"additional","affiliation":[{"name":"Department of Biology, Tor Vergata University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Romeo","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care, Section of Cardiology, Policlinic of Tor Vergata"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Novelli","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, Tor Vergata University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Sangiuolo","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, Tor Vergata University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Towbin JA. Inherited cardiomyopathies. <i>Circ J<\/i> 2014; 78: 2347\u20132356.","DOI":"10.1253\/circj.CJ-14-0893"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Doolan A, Nguyen L, Semsarian C. Hypertrophic cardiomyopathy: From \u201cheart tumour\u201d to a complex molecular genetic disorder. <i>Heart Lung Circ<\/i> 2004; 13: 15\u201325.","DOI":"10.1016\/j.hlc.2004.01.026"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Brown DW, Giles WH, Croft JB. Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension. <i>Am Heart J<\/i> 2000; 140: 848\u2013856.","DOI":"10.1067\/mhj.2000.111112"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hill JA. Hypertrophic reprogramming of the left ventricle: Translation to the ECG. <i>J Electrocardiol<\/i> 2012; 45: 624\u2013629.","DOI":"10.1016\/j.jelectrocard.2012.08.003"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Wilde AA, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P, et al. Proposed diagnostic criteria for the Brugada syndrome: Consensus report. <i>Circulation<\/i> 2002; 106: 2514\u20132519.","DOI":"10.1161\/01.CIR.0000034169.45752.4A"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Atarashi H, Ogawa S, Harumi K, Sugimoto T, Inoue H, Murayama M, et al. Three-year follow-up of patients with right bundle branch block and ST segment elevation in the right precordial leads. <i>J Am Coll Cardiol<\/i> 2001; 37: 1916\u20131920.","DOI":"10.1016\/S0735-1097(01)01239-6"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hermida J, Lemoine J, Aoun F, Jarry G, Rey J, Quiret J. Prevalence of the Brugada syndrome in an apparently healthy population. <i>Am J Cardiol<\/i> 2000; 86: 91\u201394.","DOI":"10.1016\/S0002-9149(00)00835-3"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Antzelevitch C, Pollevick G, Cordeiro J, Casis O, Sanguinetti MC, Aizawa Y, et al. Loss-of-function mutations in the cardiac calcium channel underlies a new clinical entity characterized by ST segment elevation, short QT intervals, and sudden cardiac death. <i>Circulation<\/i> 2007; 115: 442\u2013449.","DOI":"10.1161\/CIRCULATIONAHA.106.668392"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Crotti L, Marcou CA, Tester DJ, Castelletti S, Giudicessi JR, Torchio M, et al. Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: Implications for genetic testing. <i>J Am Coll Cardiol<\/i> 2012; 60: 1410\u20131418.","DOI":"10.1016\/j.jacc.2012.04.037"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Brugada P, Brugada J, Roy D. Brugada syndrome 1992\u20132012: 20 years of scientific excitement, and more. <i>Eur Heart J<\/i> 2013; 34: 3610\u20133615.","DOI":"10.1093\/eurheartj\/eht113"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). <i>Eur Heart J<\/i> 2014; 35: 2733\u20132779.","DOI":"10.1093\/eurheartj\/ehu284"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Cheng J, Morales A, Siegfried JD, Li D, Norton N, Song J, et al. SCN5A rare variants in familial dilated cardiomyopathy decrease peak sodium current depending on the common polymorphism H558R and common splice variant Q1077del. <i>Clin Transl Sci<\/i> 2010; 3: 287\u2013294.","DOI":"10.1111\/j.1752-8062.2010.00249.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Li Q, Dai Y, Guo L, Liu Y, Hao C, Wu G, et al. Polycystin-2 associates with tropomyosin-1, an actin microfilament component. <i>J Mol Biol<\/i> 2003; 325: 949\u2013962.","DOI":"10.1016\/S0022-2836(02)01333-5"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Xu C, Rossetti S, Jiang L, Harris PC, Brown-Glaberman U, Wandinger-Ness A, et al. Human ADPKD primary cyst epithelial cells with a novel, single codon deletion in the PKD1 gene exhibit defective ciliary polycystin localization and loss of flow-induced Ca2+ signaling. <i>Am J Physiol Renal Physiol<\/i> 2007; 292: F930\u2013F945.","DOI":"10.1152\/ajprenal.00285.2006"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Paavola J, Schliffke S, Rossetti S, Kuo IY, Yuan S, Sun Z, et al. Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathy. <i>J Mol Cell Cardiol<\/i> 2013; 58: 199\u2013208.","DOI":"10.1016\/j.yjmcc.2013.01.015"},{"key":"16","unstructured":"16. Roma-Rodrigues C, Fernandes AR. Genetics of hypertrophoic cardyomiopathy: Advances and pitfalls in molecular diagnosis and therapy. <i>Appl Clin Genet<\/i> 2014; 7: 195\u2013208."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Fatkin D, Graham RM. Molecular mechanisms of inherited cardiomyopathies. <i>Physiol Rev<\/i> 2002; 82: 945\u2013980.","DOI":"10.1152\/physrev.00012.2002"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Varnava AM, Elliott PM, Mahon N, Davies MJ, McKenna WJ. Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. <i>Am J Cardiol<\/i> 2001; 88: 275\u2013279.","DOI":"10.1016\/S0002-9149(01)01640-X"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Charron P, Komajda M. Molecular genetics in hypertrophic cardiomyopathy: Towards individualized management of the disease. <i>Expert Rev Mol Diagn<\/i> 2006; 6: 65\u201378.","DOI":"10.1586\/14737159.6.1.65"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Ho CY, Seidman CE. A contemporary approach to hypertrophic cardiomyopathy. <i>Circulation<\/i> 2006; 113: e858\u2013e862, doi:10.1161\/CIRCULATIONAHA.105.591982.","DOI":"10.1161\/CIRCULATIONAHA.105.591982"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Woo A, Rakowski H, Liew JC, Zhao MS, Liew CC, Parker TG, et al. Mutations of the beta myosin heavy chain gene in hypertrophic cardiomyopathy: Critical functional sites determine prognosis. <i>Heart<\/i> 2003; 89: 1179\u20131185.","DOI":"10.1136\/heart.89.10.1179"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Niimura H, Patton KK, McKenna WJ, Soults J, Maron BJ, Seidman JG, et al. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. <i>Circulation<\/i> 2002; 105: 446\u2013451.","DOI":"10.1161\/hc0402.102990"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Moolman JC, Corfield VA, Posen B, Ngumbela K, Seidman C, Brink PA, et al. Sudden death due to troponin T mutations. <i>J Am Coll Cardiol<\/i> 1997; 29: 549\u2013555.","DOI":"10.1016\/S0735-1097(96)00530-X"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Varnava AM, Elliott PM, Baboonian C, Davison F, Davies MJ, McKenna WJ. Hypertrophic cardiomyopathy: Histopathological features of sudden death in cardiac troponin T disease. <i>Circulation<\/i> 2001; 104: 1380\u20131384.","DOI":"10.1161\/hc3701.095952"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kimura A, Harada H, Park JE, Nishi H, Satoh M, Takahashi M. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. <i>Nat Genet<\/i> 1997; 16: 379\u2013382.","DOI":"10.1038\/ng0897-379"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Antzelevitch C, Brugada P, Borggrefe M, Brugada J. Brugada syndrome: Report of the second consensus conference, endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. <i>Circulation<\/i> 2005; 111: 659\u2013670.","DOI":"10.1161\/01.CIR.0000152479.54298.51"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, et al. HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). <i>Heart Rhythm<\/i> 2011; 8: 1308\u20131339.","DOI":"10.1016\/j.hrthm.2011.05.020"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Keren A, Syrris P, McKenna WJ. Hypertrophic cardiomyopathy: The genetic determinants of clinical disease expression. <i>Nat Clin Pract Cardiovasc Med<\/i> 2008; 5: 158\u2013168.","DOI":"10.1038\/ncpcardio1110"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Campuzano O, Allegue C, Iglesias A, Brugada R. Genetic basis of Brugada syndrome. <i>J Genet Syndr Gene Ther<\/i> 2013; 4: 7, doi:10.4172\/2157-7412.1000167.","DOI":"10.4172\/2157-7412.1000167"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kanters JK, Yuan L, Hedley PL, Stoevring B, Jons C, Bloch Thomsen PE, et al. Flecainide provocation reveals concealed Brugada syndrome in a long QT syndrome family with a novel L1786Q mutation in SCN5A. <i>Circ J<\/i> 2014; 78: 1136\u20131143.","DOI":"10.1253\/circj.CJ-13-1167"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. McNally EM, Golbus JR, Puckelwartz MJ. Genetic mutations and mechanisms in dilated cardiomyopathy. <i>J Clin Invest<\/i> 2013; 123: 19\u201326.","DOI":"10.1172\/JCI62862"},{"key":"32","unstructured":"32. Lopes LR, Sirris P, Guttmann OP, O\u2019Mahony C, Tang HC, Dalageorgou C, et al. Novel genotype phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy. <i>Heart<\/i> 2014; 0: 1\u20138."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Olson TM, Kishimoto NY, Whitby FG, Michels VV. Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. <i>J Molec Cell Cardiol<\/i> 2001; 33: 723\u2013732.","DOI":"10.1006\/jmcc.2000.1339"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Probst S, Oechslin E, Schuler P, Greutmann M, Boye P, Knirsch W, et al. Sarcomere gene mutations in isolated left ventricular noncompaction cardiomyopathy do not predict clinical phenotype. <i>Circ Cardiovasc Genet<\/i> 2011; 4: 367\u2013374.","DOI":"10.1161\/CIRCGENETICS.110.959270"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. White SP, Cohen C, Phillips GN Jr. Structure of co-crystals of tropomyosin and troponin. <i>Nature<\/i> 1987; 325: 826\u2013828.","DOI":"10.1038\/325826a0"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Palm T, Graboski S, Hitchcock-DeGregori SE, Greenfield NJ. Disease-causing mutations in cardiac troponin T: Identification of a critical tropomyosin-binding region. <i>Biophys J<\/i> 2001; 81: 2827\u20132837.","DOI":"10.1016\/S0006-3495(01)75924-3"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Haruki S, Minami Y, Suzuki A, Hagiwara N. Effects of flecainide on left ventricular pressure gradient and symptoms in obstructive hypertrophic cardiomyopathy: A comparison of flecainide and disopyramide. <i>Heart Vessels<\/i> 2015; 30: 604\u2013610.","DOI":"10.1007\/s00380-014-0534-3"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/80\/4\/80_CJ-15-0685\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T03:55:17Z","timestamp":1498276517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/80\/4\/80_CJ-15-0685\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-15-0685","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}